Biomarker-Guided and Imaging-Based Evaluation of Treatment Response in Hepatocellular Carcinoma: Current Evidence and Future Perspectives

Authors

  • Amany Mohammed Ibrahim, Fady Maher Wadea, Sameh Saber Bayoumi , Marwa Mohammed Esawy , Heba Sayed Ahmed Abdel Hamid Elsayed Author

DOI:

https://doi.org/10.48047/zbyzm972

Keywords:

Biomarker-Guided, Imaging, Hepatocellular Carcinoma.

Abstract

Hepatocellular carcinoma (HCC) remains a major global health challenge as the most common primary liver malignancy and a leading cause of cancer-related death. Despite advances in systemic therapies and locoregional approaches, evaluating treatment response remains

Downloads

Download data is not yet available.

References

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2020: GLOBOCAN estimates. CA Cancer J Clin. 2021;71(3):209-249.

Tzartzeva K, Obi J, Rich NE, et al. Surveillance imaging and biomarkers in hepatocellular carcinoma. Gastroenterology. 2018;154(6):1706-1718.

Downloads

Published

2024-11-30

Issue

Vol. 53 No. 03 (2024): Year 2024, Volume 53, Issue 3

Section

Original

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

Biomarker-Guided and Imaging-Based Evaluation of Treatment Response in Hepatocellular Carcinoma: Current Evidence and Future Perspectives (Amany Mohammed Ibrahim, Fady Maher Wadea, Sameh Saber Bayoumi , Marwa Mohammed Esawy , Heba Sayed Ahmed Abdel Hamid Elsayed , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 5477-5481. https://doi.org/10.48047/zbyzm972